As the expression of ABC transporters in general increases the efflux of therapeutic drugs, and thus limits treatment efficacy, we tested the ability of the two CRC cell panels with differential MACC1 expression to regulate intracellular accumulation of doxorubicin. Here, ABCG2 is linked to colorectal carcinoma.